| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.42 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.03 |